Edition:
United Kingdom

JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

7,560JPY
16 Aug 2019
Change (% chg)

¥210 (+2.86%)
Prev Close
¥7,350
Open
¥7,340
Day's High
¥7,660
Day's Low
¥7,320
Volume
140,400
Avg. Vol
108,245
52-wk High
¥7,810
52-wk Low
¥4,260

Latest Key Developments (Source: Significant Developments)

Mesoblast Expands Partnership With JCR Pharmaceuticals In Japan
Tuesday, 11 Jun 2019 

June 11 (Reuters) - Mesoblast Ltd ::MESOBLAST LTD - AGREEMENT HAS NOW BEEN FURTHER EXPANDED TO PROVIDE JCR WITH RIGHTS TO SELL TEMCELL FOR HIE .MESOBLAST LTD - JCR PLANS TO INITIATE A CLINICAL TRIAL OF TEMCELL IN NEWBORNS WITH HIE IN JULY 2019 .MESOBLAST AND JCR PHARMACEUTICALS EXPAND JAPAN LICENSE AGREEMENT TO USE OF MESENCHYMAL STEM CELLS IN NEWBORNS WITH INSUFFICIENT BLOOD FLOW TO THE BRAIN.MESOBLAST LTD - EXPANDED ITS PARTNERSHIP WITH JCR PHARMACEUTICALS CO. LTD. IN JAPAN.MESOBLAST LTD - DEAL FOR USE OF MESENCHYMAL STEM CELLS (MSCS) FOR TREATMENT OF NEWBORNS WHO LACK SUFFICIENT BLOOD SUPPLY AND OXYGEN TO BRAIN.  Full Article

JCR Pharmaceuticals to set up investigational new drug production center with investment of 3 bln yen
Thursday, 26 Apr 2018 

April 26 (Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:Says it will set up an investigational new drug production center with investment of about 3 billion yen from March 2019 .  Full Article

Medipal Holdings signs contract to set up JV JCR USA with JCR Pharmaceuticals
Tuesday, 19 Dec 2017 

Dec 19(Reuters) - Medipal Holdings Corp <7459.T>:Says it signed a contract to set up a JV JCR USA Inc with JCR Pharmaceuticals Co Ltd <<<4552.T>>>.Says the JV will be established in January 2018.Says the company and JCR Pharmaceuticals will hold a 35 percent stake and a 65 percent stake in the JV respectively .  Full Article

JCR Pharmaceuticals to initiate development of JR-171, new drug candidate for Hurler Syndrome using J-Brain Cargo
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:Says it will initiate development of JR-171, new drug candidate for Hurler Syndrome using J-Brain Cargo.  Full Article

JCR Pharmaceuticals submits application for marketing approval of JR-051 for Fabry disease
Friday, 29 Sep 2017 

Sept 29 (Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:Says it has submitted an application for marketing approval on JR-051 (recombinant alpha-galactosidase A), an enzyme replacement therapy (ERT) for Fabry disease to Ministry of Health, Labour and Welfare.  Full Article

JCR Pharmaceuticals completes share repurchase through ToSTNeT-3
Friday, 22 Sep 2017 

Sept 22 (Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:* Says it completed repurchase of 854,100 shares of its common stock, for 2.62 billion yen in total, through ToSTNeT-3,.  Full Article

JCR Pharmaceuticals to repurchase shares
Thursday, 21 Sep 2017 

Sept 21(Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:Says it will repurchase up to 940,000 shares of its common stock, representing 2.7 percent of outstanding, on Sept. 22.Share repurchase price is 3,070 yen per share, the closing price of Sept. 21, or up to 2.89 billion yen in total.  Full Article

JCR Pharmaceuticals announces shareholding structure change
Thursday, 21 Sep 2017 

Sept 21(Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:Says its top shareholder GLAXO GROUP LIMITED will cut voting power in the company to 0 percent from 25.2 percent.Says Medipal Holdings Corp <<<7459.T>>> will increase voting power in the company to 23 percent from 0.5 percent, and will become top shareholder of the company.Effective late October.  Full Article

JCR Pharmaceuticals announces business and capital alliance with Medipal Holdings
Thursday, 21 Sep 2017 

Sept 21(Reuters) - JCR Pharmaceuticals Co Ltd <4552.T>:Says it signed a business and capital alliance with Medipal Holdings Corp <<<7459.T>>>.Says the two companies will set up a joint venture in U.S..Says Medipal Holdings will acquire 22 percent stake in the company for 21.18 billion yen, and will increase stake in the company to 22.5 percent from 0.5 percent, with acquisition date in late October .  Full Article